Examining the Risks and Benefits of IPO Alternatives: Direct Listings & SPACS
30 April 2021
Louis Lehot, partner with Foley & Lardner LLP, recently published an article with Westlaw Today, “Examining the Risks and Benefits of IPO Alternatives: Direct Listings & SPACs.” The article looks at the traditional IPO process in comparison to the alternatives that are now growing in popularity.
Author(s)
Related Insights
16 January 2025
Events
Silicon Slopes Summit 2025 Networking Reception
As Foley & Lardner continues to support Silicon Slopes Summit, our Innovative Technology sector has teamed up with Trustpoint.One, Silicon Valley Bank, Ampleo, and Tanner LLC to keep the conversation going after day four.
04 December 2024
Events
Data Privacy Minefields: Mastering FDA Compliance and Privacy Standards for Drug and Device Manufacturers
Foley partner Aaron Tantleff is speaking in the American Conference Institute’s 29th Annual Conference on Drug & Medical Device Litigation in a session titled “Data Privacy Minefields: Mastering FDA Compliance and Privacy Standards for Drug and Device Manufacturers.”
20 November 2024
PharmaPatents
USPTO Publishes Final Fees for 2025
The USPTO has published its final rule setting patent fees that will take effect January 19, 2025.